Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
Centre Oscar Lambret
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana
The Institute of Molecular and Translational Medicine, Czech Republic
Dana-Farber Cancer Institute
National University Hospital, Singapore
Boehringer Ingelheim
Boston Children's Hospital
City of Hope Medical Center